Texas Capital Bancshares, Inc.
TCBIO
Last
$18.28
Day
+0.0%
1y
-15.3%
5y
-30.7%
52w
-20.3%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
19.07
EMA 50
19.65
EMA 200
20.53
20d high
-9.1%
5y high
-32.9%
5y range
41th
Positions held
Your positionsTCBIO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$19.14
Stop
$17.57
Stop distance
3.9%
Target vs last
+4.7%
Fundamentals
| Market cap | — | Enterprise value | -$1.61B | Trailing P/E | 4.62 | Forward P/E | — |
| PEG | — | Price / book | 0.24 | Beta | 0.63 | Dividend yield | 7.88% |
| Revenue growth | 8.6% | Earnings growth | 15.8% | Gross margin | 0.0% | Operating margin | 36.7% |
| Profit margin | 28.7% | ROE | 10.2% | ROA | 1.1% | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $22.95 | 52w low | $17.96 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $335M | $324M | $327M | $340M | $307M |
| Op margin | — | — | — | — | — |
| Net income | $84.9M | $73.8M | $101M | $105M | $77.3M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
- Revenue +4% vs prior quarter ($335M vs $324M).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.3B | $932M | $1.1B | $977M | — |
| Op margin | — | — | — | — | — |
| Net income | $330M | $77.5M | $189M | $332M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsTCBIO · daily-5.2% over 12 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin